Eli Lilly sues Canadian government for “unfair” patent rulings

17-09-2013

Eli Lilly sues Canadian government for “unfair” patent rulings

Eli Lilly has filed a Notice of Arbitration (NOA) against the Canadian government, alleging recent decisions that invalidated patents covering its Zyprexa and Strattera drugs were in breach of the North American Free Trade Agreement (NAFTA).


Eli Lilly, Canada, Strattera, Zyprexa, promise utility doctrine

More on this story

Canada responds to Lilly’s NAFTA complaint
15-07-2014

LSIPR